1679823601_Esmo-prostate-4.png

STAMPEDE trial

Oncologyme  /  Mar 26, 2023

The combination of #Enzalutamide (ENZ) Plus #Abiraterone Acetate and Prednisolone (AAP) is NOT Recommended for #mHSPC based on the recent data from #STAMPEDE study that was presented by Dr. Gerhardt Attard. Using meta-analysis testing methods, Results from 2 trials have showed similar OS benefit from adding AAP to ADT alone (HR= 0.62) or ADT+ ENZ (HR= 0.65).